AAV9.hMCOLN1co

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NameAAV9.hMCOLN1co
Drug Alias NameAAV9.hMCOLN1co
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMucolipidoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe Children'S Hospital, Zhejiang University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesThe Children'S Hospital, Zhejiang University School Of Medicine
Inactive CompaniesN/A
Active IndicationsMucolipidoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A